Winston Tan, M.D., is focused on translating basic science principles into tangible treatment options for patients with cancer.
He is interested in the importance of molecular pathways, such as those related to the estrogen receptor, vascular endothelial factor and HER-2 receptor, in the pathogenesis and therapy of cancer.
- Developing novel hormonal strategies to abrogate the pathway of resistance in breast cancer, prostate cancer and bladder cancer
- Identifying molecular markers that will predict response and toxicity to targeted treatment
- Identifying and developing novel targets for kidney cancer, including predictors of treatment response and resistance
Significance to patient care
The development of novel targets of therapy would lead to oral and less toxic treatments for cancer. These treatments would also be able to lead to meaningful improvement of quality of life, prolongation of the time to cancer progression and hopefully improved survival.
- Board Member, Florida Society of Clinical Oncology
- Fellow, American College of Physicians
- Member, Membership Committee, American Society of Clinical Oncology
See my publications
- Associate Professor of Medicine
- Clinical Fellowship - Hematology and Medical Oncology University of Texas Health Science Center at San Antonio
- Research Fellowship - Translational laboratory breast cancer research under Dr. Douglas Yee and Adrian Lee- insulin growth factor pathways in breast cancer University of Texas at San Antonio
- Senior Research Fellowship - Clinical research and protocol development, writing under Professor Peter Ravdin University of Texas at San Antonio
- Resident - Internal Medicine Maimonides Medical Center
- Resident - Internal Medicine Chinese General Hospital
- Rotating Internship - General Medical, Pediatric, Obstetrics & Gynecology, General Surgery Training Chinese General Hospital
- MD - Doctor of Medicine University of Santo Tomas
- BS - Biology University of Santo Tomas